Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis

J Neuroophthalmol. 2011 Sep;31(3):292-3. doi: 10.1097/WNO.0b013e31822bed20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Blindness / chemically induced*
  • Blindness / diagnosis
  • Blindness / physiopathology
  • Female
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Propylene Glycols / adverse effects*
  • Retinal Vein / drug effects
  • Retinal Vein / pathology
  • Retinal Vein Occlusion / chemically induced*
  • Retinal Vein Occlusion / diagnosis
  • Retinal Vein Occlusion / physiopathology
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine